GT200900060A - Procedimiento de preparación de halogenuros de n-alquil-naltrexona - Google Patents
Procedimiento de preparación de halogenuros de n-alquil-naltrexonaInfo
- Publication number
- GT200900060A GT200900060A GT200900060A GT200900060A GT200900060A GT 200900060 A GT200900060 A GT 200900060A GT 200900060 A GT200900060 A GT 200900060A GT 200900060 A GT200900060 A GT 200900060A GT 200900060 A GT200900060 A GT 200900060A
- Authority
- GT
- Guatemala
- Prior art keywords
- carbonate
- methyl
- preparation procedure
- naltrexona
- halogenure
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- IFGIYSGOEZJNBE-KNLJMPJLSA-N (4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-3-ium-7-one;bromide Chemical compound [Br-].C[N+]1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@@H]3[C@]4([C@@]2(O)CCC3=O)CC1)CC1CC1 IFGIYSGOEZJNBE-KNLJMPJLSA-N 0.000 abstract 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 abstract 1
- 229910000024 caesium carbonate Inorganic materials 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 abstract 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 abstract 1
- 239000001095 magnesium carbonate Substances 0.000 abstract 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 abstract 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 abstract 1
- JVLBPIPGETUEET-GAAHOAFPSA-O methylnaltrexone Chemical compound C[N+]1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@@H]3[C@]4([C@@]2(O)CCC3=O)CC1)CC1CC1 JVLBPIPGETUEET-GAAHOAFPSA-O 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910000027 potassium carbonate Inorganic materials 0.000 abstract 1
- 239000012429 reaction media Substances 0.000 abstract 1
- 229910000029 sodium carbonate Inorganic materials 0.000 abstract 1
- 229910000018 strontium carbonate Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA INVENCIÓN SE REFIERE A UN NUEVO PROCEDIMIENTO DE PREPARACIÓN DEL BROMURO DE N-METIL-NALTREXONA, QUE COMPRENDE AL MENOS LAS ETAPAS QUE CONSISTEN EN: (I) HACER REACCIONAR EL METILSULFATO DE N-METIL-NALTREXONA EN SOLUCIÓN ACUOSA CON UN AGENTE ALCALINO ELEGIDO DEL GRUPO CONSTITUIDO POR CARBONATO DE SODIO, CARBONATO DE POTASIO, CARBONATO DE CALCIO, CARBONATO DE MAGNESIO, CARBONATO DE CESIO, CARBONATO DE ESTRONCIO Y LAS MEZCLAS DE ESTOS, PARA UN PH DEL MEDIO DE REACCIÓN ACUOSO COMPRENDIDO ENTRE 7 Y 10, Y DESPUÉS (II) HACER REACCIONAR EL PRODUCTO ASÍ OBTENIDO CON EL ÁCIDO BROMHÍDRICO QUE SE AÑADE, PARA UN PH DEL MEDIO DE REACCIÓN ACUOSO COMPRENDIDO ENTRE 5,5 Y 5 Y OBTENER ASÍ EL BROMURO DE N-METIL-NALTREXONA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0608286A FR2906252B1 (fr) | 2006-09-21 | 2006-09-21 | Procede de preparation d'halogenures de n-aklyl naltrexone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200900060A true GT200900060A (es) | 2011-01-04 |
Family
ID=38016779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200900060A GT200900060A (es) | 2006-09-21 | 2009-03-12 | Procedimiento de preparación de halogenuros de n-alquil-naltrexona |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US7645880B2 (es) |
| EP (1) | EP2069362B1 (es) |
| JP (1) | JP5214615B2 (es) |
| KR (1) | KR101434693B1 (es) |
| CN (2) | CN101516892B (es) |
| AR (1) | AR062918A1 (es) |
| AU (1) | AU2007298855B2 (es) |
| BR (1) | BRPI0718440A2 (es) |
| CA (1) | CA2663509C (es) |
| CL (1) | CL2007002711A1 (es) |
| CO (1) | CO6170362A2 (es) |
| CR (1) | CR10660A (es) |
| DO (1) | DOP2011000307A (es) |
| EA (1) | EA015426B1 (es) |
| ES (1) | ES2531093T3 (es) |
| FR (1) | FR2906252B1 (es) |
| GT (1) | GT200900060A (es) |
| HN (1) | HN2009000503A (es) |
| IL (1) | IL197402A (es) |
| JO (1) | JO3023B1 (es) |
| MA (1) | MA30793B1 (es) |
| ME (1) | MEP10509A (es) |
| MX (1) | MX2009003084A (es) |
| MY (1) | MY148094A (es) |
| NI (1) | NI200900035A (es) |
| NO (1) | NO20091561L (es) |
| NZ (1) | NZ575417A (es) |
| PE (1) | PE20080867A1 (es) |
| SV (1) | SV2009003192A (es) |
| TN (1) | TN2009000080A1 (es) |
| TW (1) | TWI465451B (es) |
| UA (1) | UA96957C2 (es) |
| UY (1) | UY30599A1 (es) |
| WO (1) | WO2008034973A1 (es) |
| ZA (1) | ZA200901846B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3263571B2 (en) | 2007-03-29 | 2023-08-23 | Progenics Pharmaceuticals, Inc. | Crystal form of (r)-n-methylnaltrexone bromide and uses thereof |
| WO2008138383A1 (de) * | 2007-05-16 | 2008-11-20 | Cilag Ag | Verfahren zur herstellung von n-methylnaltrexonbromid |
| US8383649B2 (en) * | 2007-07-11 | 2013-02-26 | Mallinckrodt Llc | Crystalline forms of naltrexone methobromide |
| EP2019105A1 (en) * | 2007-07-19 | 2009-01-28 | Siegfried Ltd. | Process for the preparation of quaternary n-alkyl morphine or morphinane alkaloid derivatives |
| CN102227433B (zh) * | 2008-09-30 | 2015-01-07 | 马林克罗特有限公司 | 烷基化吗啡喃衍生物的仲胺基团的方法 |
| WO2010096791A1 (en) * | 2009-02-23 | 2010-08-26 | Mallinckrodt Inc. | (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
| JP2012518651A (ja) * | 2009-02-23 | 2012-08-16 | マリンクロッド インコーポレイテッド | （＋）−モルフィナニウムｎ−オキシドおよびそれらの生成方法 |
| US8946419B2 (en) | 2009-02-23 | 2015-02-03 | Mallinckrodt Llc | (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
| WO2010096788A1 (en) * | 2009-02-23 | 2010-08-26 | Mallinckrodt Inc. | (+)-morphinanium quaternary salts and processes for their production |
| AU2010239059B2 (en) | 2009-04-24 | 2016-06-09 | Brock University | Processes for the preparation of morphinane and morphinone compounds |
| WO2011009020A2 (en) | 2009-07-16 | 2011-01-20 | Mallinckrodt Inc. | Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
| CN101845047B (zh) * | 2009-12-31 | 2011-12-07 | 南京臣功制药有限公司 | 一种溴甲基纳曲酮的制备方法 |
| AU2011325563B2 (en) * | 2010-11-05 | 2015-08-20 | H. Lundbeck A/S | Method for the manufacturing of naltrexone |
| US8580963B2 (en) | 2010-11-05 | 2013-11-12 | H. Lundbeck A/S | Method for the manufacturing of naltrexone |
| JO3209B1 (ar) * | 2010-11-05 | 2018-03-08 | H Lundbeck As | طريقة لتصنيع نالتريكسون |
| US9029543B2 (en) | 2011-04-05 | 2015-05-12 | Alkermes, Inc. | Process for the synthesis of quaternary amine compounds |
| KR20140063763A (ko) | 2011-09-08 | 2014-05-27 | 말린크로트 엘엘씨 | 중간체를 단리하지 않는 알칼로이드의 제조 방법 |
| CN103172640A (zh) * | 2011-12-22 | 2013-06-26 | 天津康鸿医药科技发展有限公司 | 一种(r)-n-溴甲基纳曲酮的制备方法以及纳曲酮衍生物 |
| US20140155608A1 (en) | 2012-05-03 | 2014-06-05 | H. Lundbeck A/S | Method for the manufacturing of naltrexone |
| CN105985348B (zh) * | 2015-02-12 | 2019-02-01 | 正大天晴药业集团股份有限公司 | 一种溴甲基纳曲酮的制备方法 |
| CN106317064B (zh) * | 2015-06-30 | 2018-06-19 | 北大方正集团有限公司 | 溴甲纳曲酮的制备方法 |
| KR102201609B1 (ko) * | 2019-04-19 | 2021-01-12 | 연성정밀화학(주) | 날데메딘의 제조방법 |
| CN111777617B (zh) * | 2020-07-10 | 2025-06-06 | 华润三九医药股份有限公司 | 一种溴甲纳曲酮的精制方法 |
| EP4225312A1 (en) | 2020-10-06 | 2023-08-16 | Scilex Holding Company | Oral delayed burst formulation of low-dose naltrexone or naloxone used for treating fibromyalgia and long covid |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4176186A (en) * | 1978-07-28 | 1979-11-27 | Boehringer Ingelheim Gmbh | Quaternary derivatives of noroxymorphone which relieve intestinal immobility |
| MXPA05004759A (es) * | 2002-11-08 | 2005-08-02 | Mallinckrodt Inc | Proceso para la preparacion de sales alcaloides n-alquil morfinan cuaternarias. |
| AR057325A1 (es) * | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
-
2006
- 2006-09-21 FR FR0608286A patent/FR2906252B1/fr not_active Expired - Fee Related
-
2007
- 2007-09-19 MX MX2009003084A patent/MX2009003084A/es active IP Right Grant
- 2007-09-19 CN CN2007800350747A patent/CN101516892B/zh not_active Expired - Fee Related
- 2007-09-19 CN CN2011101080743A patent/CN102225939A/zh active Pending
- 2007-09-19 JP JP2009528751A patent/JP5214615B2/ja not_active Expired - Fee Related
- 2007-09-19 ZA ZA200901846A patent/ZA200901846B/xx unknown
- 2007-09-19 KR KR1020097005731A patent/KR101434693B1/ko not_active Expired - Fee Related
- 2007-09-19 TW TW096134967A patent/TWI465451B/zh not_active IP Right Cessation
- 2007-09-19 ME MEP-105/09A patent/MEP10509A/xx unknown
- 2007-09-19 EA EA200970307A patent/EA015426B1/ru not_active IP Right Cessation
- 2007-09-19 CA CA2663509A patent/CA2663509C/fr not_active Expired - Fee Related
- 2007-09-19 BR BRPI0718440-9A2A patent/BRPI0718440A2/pt not_active IP Right Cessation
- 2007-09-19 MY MYPI20091158A patent/MY148094A/en unknown
- 2007-09-19 EP EP07848250.2A patent/EP2069362B1/fr active Active
- 2007-09-19 NZ NZ575417A patent/NZ575417A/en not_active IP Right Cessation
- 2007-09-19 UA UAA200903924A patent/UA96957C2/ru unknown
- 2007-09-19 WO PCT/FR2007/001516 patent/WO2008034973A1/fr not_active Ceased
- 2007-09-19 ES ES07848250T patent/ES2531093T3/es active Active
- 2007-09-19 AU AU2007298855A patent/AU2007298855B2/en not_active Ceased
- 2007-09-20 UY UY30599A patent/UY30599A1/es not_active Application Discontinuation
- 2007-09-20 CL CL200702711A patent/CL2007002711A1/es unknown
- 2007-09-20 PE PE2007001269A patent/PE20080867A1/es not_active Application Discontinuation
- 2007-09-20 AR ARP070104157A patent/AR062918A1/es unknown
- 2007-09-20 JO JOP/2007/0399A patent/JO3023B1/ar active
-
2008
- 2008-03-17 US US12/049,607 patent/US7645880B2/en not_active Expired - Fee Related
-
2009
- 2009-03-04 IL IL197402A patent/IL197402A/en not_active IP Right Cessation
- 2009-03-10 TN TN2009000080A patent/TN2009000080A1/fr unknown
- 2009-03-11 CR CR10660A patent/CR10660A/es unknown
- 2009-03-12 GT GT200900060A patent/GT200900060A/es unknown
- 2009-03-18 HN HN2009000503A patent/HN2009000503A/es unknown
- 2009-03-19 CO CO09028774A patent/CO6170362A2/es active IP Right Grant
- 2009-03-19 NI NI200900035A patent/NI200900035A/es unknown
- 2009-03-19 SV SV2009003192A patent/SV2009003192A/es active IP Right Grant
- 2009-04-16 MA MA31789A patent/MA30793B1/fr unknown
- 2009-04-20 NO NO20091561A patent/NO20091561L/no not_active Application Discontinuation
- 2009-11-25 US US12/625,649 patent/US8288547B2/en not_active Expired - Fee Related
-
2011
- 2011-10-07 DO DO2011000307A patent/DOP2011000307A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200900060A (es) | Procedimiento de preparación de halogenuros de n-alquil-naltrexona | |
| ES2555989T3 (es) | Procedimiento para la síntesis del ácido 2,5-furanodicarboxílico | |
| BR112012027444A2 (pt) | bloco cáustico altamente concentrado para lavagem de louças | |
| MX2009013255A (es) | Matriz de solidificacion que incluye una sal de un acido mono-, di- o tri-carboxilico saturado de cadena recta. | |
| BRPI0806702A8 (pt) | cimento de alta resistência, argamassa e concreto incluindo subprodutos industrias | |
| EA200702549A1 (ru) | Способ производства органического соединения | |
| DE602007008851D1 (de) | Ektionsmittel | |
| AR092500A1 (es) | Solucion de limpieza de colon | |
| PE20100011A1 (es) | Combinacion biocida para utilizacion en aplicaciones agricolas | |
| DK2262751T3 (da) | Anvendelse af alkalsulfonsyre som rengøringsmiddel til cement, mørtel og beton | |
| MX2009012170A (es) | Tinte de concreto basado en acido debil. | |
| AR064658A1 (es) | Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma | |
| MX2016007436A (es) | Composiciones para el cuidado oral que comprenden carbonato de calcio y talco. | |
| ES2527934T3 (es) | Placa cerámica protectora contra los incendios y procedimiento para su producción | |
| EA201490360A1 (ru) | Композиции, содержащие соли аминокислот | |
| CL2011002278A1 (es) | Proceso para la preparacion de (e)-n-(4-(3-ter-butil-5-(2,4-dioxo-3,4-dihidropirimidin-1(2h)-il)-2-metoxiestiril)fenil)metansulfonamida o su sal por reduccion del correspondiente etinilo; y los compuestos intermediarios considerados. | |
| CO5670371A2 (es) | Composiciones limpiadoras en la forma de una tableta | |
| WO2008107463A3 (en) | Solid detergent composition and process to prepare the same | |
| BRPI0516335A (pt) | composição de limpeza lìquida/gel e processo para a preparação de uma composição de limpeza lìquida/gel | |
| EP3593650A3 (en) | Preparations capable of increasing the ph of food by releasing molecular hydrogen | |
| DOP2009000041A (es) | Procedimiento de preparacion de halogenuros de n-alquil-naltrexona | |
| WO2007129184A3 (en) | An improved process for the preparation of phenytoin sodium | |
| GT200600390A (es) | Ibuprofeno solubilizado | |
| PL396849A1 (pl) | Sposób wytwarzania materialu izolacyjnego ognioodpornego | |
| AR072340A1 (es) | Procedimiento de produccion de isocianatos y carbamatos fluorados con catalizadores heterogeneos |